Summary
Updated Aug 31, 2026
Christopher Hite is EVP & Chairman, Partnering of Royalty Pharma plc (RPRX). 10 SEC Form 4 filings on record going back to 2025, most recently on 19 August 2026. Most recent open-market trade: sold $6.00M of RPRX on 19 August 2026. Lifetime open-market sales: $21.50M.
Recent Transactions
13Every recent SEC Form 4 transaction Christopher Hite has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Christopher Hite go back to 2025: 10 primary Form 4 filings, an average of 5.0 per year. 8 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Hite files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Terrance P. Coyne - $33.61M of RPRX open-market activity in the last 12 months
- George W. Lloyd - $9.57M of RPRX open-market activity in the last 12 months
- Marshall Urist - $6.54M of RPRX open-market activity in the last 12 months
- Gregory Norden - $161K of RPRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Christopher Hite?
Christopher Hite is a corporate insider, tracked as EVP & Chairman, Partnering of Royalty Pharma plc (RPRX). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher Hite submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Christopher Hite been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($21.50M) across all tracked filings.
Where can I see all of Christopher Hite's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Christopher Hite and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial